The Effect of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) on Overall Survival of Patients with Relapsed Diffuse Large B-Cell Lymphoma Post-Autologous Stem Cell Transplant
Not Applicable
- Conditions
- diffuse large B-cell lymphomaBlood - Haematological diseases
- Registration Number
- ACTRN12610000803099
- Lead Sponsor
- Haematology and Oncology Clinics (HOCA) Research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Patients with histologically-confirmed DLBCL
Must have received CHOP (CHOP 14, CHOP 21) or R-CHOP (R-CHOP 14, R-CHOP 21) chemotherapy as first-line therapy
Must have received an auto-SCT transplant after relapse
Exclusion Criteria
Patients with low-grade lymphoma at presentation or relapse.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method